about
Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibitionRHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic responseLoss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia GroupEP-01HETEROGENEITY OF RELA PROTEIN EXPRESSION IN PAEDIATRIC EPENDYMOMA.OP26DELINEATING INTRA-TUMOUR METABOLOMIC AND PHOSPHO-PROTEOMIC HETEROGENEITY IN PATIENT GLIOBLASTOMAS THROUGH ADVANCED ANALYTICAL METHODS.PO46NANOPARTICLE-ASSOCIATED CELL PENETRATING AND CYTOTOXIC PEPTIDES AS A NOVEL THERAPEUTIC STRATEGY FOR MALIGNANT GLIOMA.PO48CHARACTERISING INTRATUMOUR HETEROGENEITY IN PAEDIATRIC GLIOBLASTOMA MULTIFORME USING A NOVEL ADVANCED MASS SPECTROMETRY TECHNIQUE.
P50
Q28484418-F8723502-A1B5-45DE-9F42-71F66FAE6286Q34399645-367B4C7F-D236-4FC6-890F-03E0779BD8AAQ35758314-401680F2-BEAE-437D-A377-77C4531F51FCQ35863933-72A3DFF7-F1FA-43F2-AF44-41A736834822Q36041205-5F7EFCA1-79D3-4037-AD44-B254E6FA1FE4Q36355916-DB50692E-880F-477F-B5F6-B2F1073C23CDQ38016579-198ABD5D-D7E5-49F3-89FB-79800C625AEDQ39652042-842EA1E6-ABA0-44EB-9B6D-6976EB50FAE8Q45956942-E8869E87-C4EC-4F13-86CF-64CC47BC71E2Q45968625-0F70EEDB-D539-463B-86C4-078A91A24314Q45969114-C427EBD6-B628-4032-8A5F-50ED5A1852FEQ45969143-8F374E24-D85B-4B18-8A88-5B4489411E32
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3906-0858
@en
name
Jennifer H Ward
@ast
Jennifer H Ward
@en
Jennifer H Ward
@es
Jennifer H Ward
@nl
type
label
Jennifer H Ward
@ast
Jennifer H Ward
@en
Jennifer H Ward
@es
Jennifer H Ward
@nl
prefLabel
Jennifer H Ward
@ast
Jennifer H Ward
@en
Jennifer H Ward
@es
Jennifer H Ward
@nl
P106
P21
P31
P496
0000-0002-3906-0858